Business Context and Reporting Period
This Form 8-K is a current report filed by GP-Act III Acquisition Corp. (GPAT), a Cayman Islands exempted company and emerging growth company, on May 7, 2026. The filing addresses Item 8.01 (Other Events) regarding the company's efforts to extend its deadline to consummate an initial business combination.
Key Financial Metrics
The filing does not provide specific financial statements, revenue, profit, cash flow, or debt figures. The report focuses on corporate governance and capital structure events rather than operational financial performance. Key structural details include:
- Securities Registered: Units (GPATU), Class A ordinary shares (GPAT), and Redeemable warrants (GPATW) trading on The Nasdaq Stock Market LLC.
- Warrant Exercise Price: $11.50 per share.
- Trust Account: Established in connection with the IPO; the filing discusses extending the liquidation date of this account.
Material Changes and Events
The primary event reported is the execution of Non-Redemption Agreements in connection with an upcoming Extraordinary General Meeting. Key details include:
- Extension Proposals: The company seeks shareholder approval to extend the deadline to complete a business combination or liquidate from May 13, 2026, to November 13, 2026.
- Non-Redemption Agreements: The Sponsor (GP-Act III Sponsor LLC) intends to enter into agreements with third-party shareholders. In exchange for agreeing not to redeem shares and voting in favor of the extension, shareholders will receive a negotiated number of Class A ordinary shares following the closing of a business combination.
- Objective: These agreements aim to increase the likelihood of extension approval and preserve funds in the trust account by reducing redemptions.
Guidance, Outlook, and Risks
The filing contains forward-looking statements regarding the approval of the extension and the funds remaining in the trust account, which are subject to significant risks and uncertainties.
- Outlook: Management anticipates that the Non-Redemption Agreements will increase the funds remaining in the trust account post-meeting.
- Risks: Risks include the failure of shareholders to approve the extension, the inability to consummate a business combination, and the volume of redemption requests from public shareholders.
- Contingencies: The Non-Redemption Agreements will terminate if the extension is not approved, the company liquidates, or if a shareholder exercises redemption rights.
Investor Verification Checklist
- Verify the record date for the Extraordinary General Meeting (March 24, 2026) and the meeting date to confirm voting eligibility.
- Review the Definitive Proxy Statement (Schedule 14A) filed on March 30, 2026, for full details on the Extension Amendment and Trust Amendment proposals.
- Confirm the specific terms of the Non-Redemption Agreements, including the ratio of shares to be transferred to participating shareholders, which is stated as "to be negotiated."
- Assess the risk of liquidation if the extension proposals are not approved by shareholders by the May 13, 2026 deadline.